CCaTS: Accelerating discoveries toward better health
Mayo Clinic Center for Clinical and Translational Science (CCaTS) is a central hub for institutional advancement of research and education at Mayo Clinic. The center provides tools and expert consultation to support every aspect of medical research, including basic discovery science, clinical and community-engaged research, and late-stage application and commercialization.
CCaTS is led by Claudia Lucchinetti, M.D., principal investigator and director of CCaTS and dean for clinical and translational science at Mayo Clinic. David O. Warner, M.D., is co-principal investigator and associate director of CCaTS, and is also principal investigator of the KL2 mentored career development grant. Anthony J. Windebank, M.D., is principal investigator of the TL1 predoctoral training grant.
News
Communities of color face unique vaccination fears
Statewide, numerous initiatives are underway to convince people of color to get potentially lifesaving vaccinations. Mayo Clinic is working closely with local churches in the Rochester and Twin Cities area, as well as with local immigrant and refugee populations.
Read more in the Star Tribune.
Community-based care key to covid-19 rapid response
A Mayo Clinic study recently published in the American Journal of Public Health says easy access to rapid testing is needed to combat disparities, and a community-driven and culturally tailored strategy is key for success.
Read more on the Mayo Clinic News Network.
Celebrating Mayo Clinic women in medicine on International Women's Day
March was Women's History Month and in honor of International Women's Day on March 8, Mayo Clinic honored and recognized women's contributions in medicine and research.
Read more on the Mayo Clinic News Network.
Saving lives through innovation
A unique new startup accelerator with Mayo Clinic and ASU is supporting breakthrough innovation in the health care industry.
Read more on ASU News.
Dr. Enders to Join ACTS Board of Directors
Mayo Clinic biostatistician Felicity Enders, Ph.D., has been elected to a three-year term on the Association for Clinical and Translational Science (ACTS) Board of Directors. ACTS is a professional association that supports researchers and educators involved in the NIH Clinical and Translational Science Award Program.